EV/EBITDA Ratio: 93.79x

Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.

Is the EV/EBITDA ratio high or low?

The EV/EBITDA ratio of 93.79x is 90% below its estimated 1-year average of 953.43x, near the low end of its estimated 1-year range (93.79x–1586.99x).

As of 2026-10-06T11:05:27.037Z.

ASND EV/EBITDA Ratio Metrics

EV/EBITDA vs. estimated history

At 93.8, EV/EBITDA is at an extreme level, where the multiple carries little signal — higher than 0% of readings in its estimated 1-year history.

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

EV/EBITDA Ratio Formula & Definition

EV/EBITDA = Enterprise Value / EBITDA (TTM)

Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EV/EBITDA Ratio FAQ

What is the EV/EBITDA ratio for Ascendis Pharma A/S (ASND)?

The EV/EBITDA ratio for ASND stock is 93.79x.

Is Ascendis Pharma A/S's EV/EBITDA ratio high or low?

The EV/EBITDA ratio of 93.79x is 90% below its estimated 1-year average of 953.43x, near the low end of its estimated 1-year range (93.79x–1586.99x).

Related Metrics